390518.fig.002a
(a)
390518.fig.002b
(b)
390518.fig.002c
(c)
390518.fig.002d
(d)
390518.fig.002e
(e)
390518.fig.002f
(f)
390518.fig.002g
(g)
390518.fig.002h
(h)
390518.fig.002i
(i)
390518.fig.002j
(j)
390518.fig.002k
(k)
390518.fig.002l
(l)
Figure 2: Micrographs of hematoxylin-eosin-stained tissue implanted with PLGA random nanofibers at (a) 2 weeks, (b) 4 weeks, and (c) 8 weeks; with PLGA-undoped PHT random fibers at (d) 2 weeks, (e) 4 weeks, and (f) 8 weeks; with PLGA-doped PHT random fibers at (g) 2 weeks, (h) 4 weeks, and (i) 8 weeks; and with PLGA-doped PHT aligned nanofibers at (j) 2 weeks, (k) 4 weeks, and (l) 8 weeks. C: collagen; L: lymphocytes; M: macrophages; F: fibroblast; G: giant cell; and arrows indicate implant sites.